Letter to the Editor: Popsicle Politics
By Marcy Darnovsky,
Mother Jones
| 08. 31. 2006
Both "Breeder Reaction" and "Souls on Ice" begin to tackle the profound issues and difficult questions raised by new human biotechnologies: How do we take reproductive and genetic technologies out of the free-market realm of anything-goes-for-those-who-can-pay, while making sure that we protect reproductive rights? How do we reap the potential benefits of human biotech, while making sure that we're not on the road either to a brave new world of designer babies or to ever greater health inequities because of hugely expensive designer medicine?
A number of countries, including Canada and the United Kingdom, have put in place comprehensive policies to regulate assisted reproduction and research that involves human embryos. But not the United States—here again, we're a Wild West, with scant public oversight.
Related Articles
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...
By Marianne Lamers, NEMO Kennislink [cites CGS' Katie Hasson] | 09.23.2025
Een rijtje gespreide vulva’s gaapt de bezoeker aan. Zó ziet een bevalling eruit, en zó een baarmoeder met foetus. Een zwangerschap, maar dan zonder zwangere vrouw, gestript van zorgen, gêne en pijn. De zwangerschapsmodellen en oefenbekkens, te zien in de...